Magnesium in PDB 4tq9: Crystal Structure of A Gdp-Bound G12V Oncogenic Mutant of Human Gtpase Kras
Protein crystallography data
The structure of Crystal Structure of A Gdp-Bound G12V Oncogenic Mutant of Human Gtpase Kras, PDB code: 4tq9
was solved by
J.C.Hunter,
A.Manandhar,
D.Gurbani,
Z.Chen,
K.D.Westover,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
37.05 /
1.49
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
65.320,
41.427,
115.119,
90.00,
105.09,
90.00
|
R / Rfree (%)
|
16.4 /
19.4
|
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Crystal Structure of A Gdp-Bound G12V Oncogenic Mutant of Human Gtpase Kras
(pdb code 4tq9). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 2 binding sites of Magnesium where determined in the
Crystal Structure of A Gdp-Bound G12V Oncogenic Mutant of Human Gtpase Kras, PDB code: 4tq9:
Jump to Magnesium binding site number:
1;
2;
Magnesium binding site 1 out
of 2 in 4tq9
Go back to
Magnesium Binding Sites List in 4tq9
Magnesium binding site 1 out
of 2 in the Crystal Structure of A Gdp-Bound G12V Oncogenic Mutant of Human Gtpase Kras
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Crystal Structure of A Gdp-Bound G12V Oncogenic Mutant of Human Gtpase Kras within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg202
b:12.8
occ:1.00
|
O
|
A:HOH406
|
2.0
|
12.3
|
1.0
|
O
|
A:HOH408
|
2.1
|
12.5
|
1.0
|
O2B
|
A:GDP201
|
2.1
|
11.2
|
1.0
|
OG
|
A:SER17
|
2.1
|
11.6
|
1.0
|
O
|
A:HOH311
|
2.1
|
12.9
|
1.0
|
O
|
A:HOH407
|
2.2
|
12.6
|
1.0
|
HB2
|
A:SER17
|
3.1
|
13.2
|
1.0
|
CB
|
A:SER17
|
3.2
|
11.0
|
1.0
|
PB
|
A:GDP201
|
3.3
|
12.3
|
1.0
|
H
|
A:SER17
|
3.3
|
13.9
|
1.0
|
HA
|
A:PRO34
|
3.4
|
15.9
|
1.0
|
HD2
|
A:TYR32
|
3.5
|
21.3
|
1.0
|
O1B
|
A:GDP201
|
3.5
|
13.1
|
1.0
|
HB3
|
A:SER17
|
3.8
|
13.2
|
1.0
|
N
|
A:SER17
|
3.9
|
11.6
|
1.0
|
HB2
|
A:LYS16
|
3.9
|
14.1
|
1.0
|
HE2
|
A:TYR32
|
4.0
|
21.2
|
1.0
|
CA
|
A:SER17
|
4.1
|
9.9
|
1.0
|
OD2
|
A:ASP57
|
4.1
|
13.3
|
1.0
|
O1A
|
A:GDP201
|
4.1
|
15.1
|
1.0
|
HE2
|
A:LYS16
|
4.2
|
15.1
|
1.0
|
OD1
|
A:ASP57
|
4.2
|
13.5
|
1.0
|
O
|
A:PRO34
|
4.2
|
13.4
|
1.0
|
CD2
|
A:TYR32
|
4.3
|
17.8
|
1.0
|
CA
|
A:PRO34
|
4.3
|
13.3
|
1.0
|
O
|
A:ASP33
|
4.3
|
15.8
|
1.0
|
O3B
|
A:GDP201
|
4.3
|
11.8
|
1.0
|
O3A
|
A:GDP201
|
4.4
|
12.6
|
1.0
|
HA
|
A:SER17
|
4.4
|
11.9
|
1.0
|
O
|
A:ILE36
|
4.4
|
13.6
|
1.0
|
CG
|
A:ASP57
|
4.5
|
12.2
|
1.0
|
CE2
|
A:TYR32
|
4.6
|
17.7
|
1.0
|
C
|
A:PRO34
|
4.6
|
13.1
|
1.0
|
O
|
A:THR58
|
4.6
|
12.7
|
1.0
|
PA
|
A:GDP201
|
4.6
|
13.6
|
1.0
|
HB1
|
A:ALA59
|
4.6
|
17.6
|
1.0
|
HZ3
|
A:LYS16
|
4.7
|
16.0
|
1.0
|
O2A
|
A:GDP201
|
4.7
|
13.4
|
1.0
|
HZ2
|
A:LYS16
|
4.8
|
16.0
|
1.0
|
HA
|
A:ALA59
|
4.8
|
14.9
|
1.0
|
CB
|
A:LYS16
|
4.8
|
11.8
|
1.0
|
O
|
A:HOH321
|
5.0
|
16.7
|
1.0
|
C
|
A:LYS16
|
5.0
|
10.8
|
1.0
|
|
Magnesium binding site 2 out
of 2 in 4tq9
Go back to
Magnesium Binding Sites List in 4tq9
Magnesium binding site 2 out
of 2 in the Crystal Structure of A Gdp-Bound G12V Oncogenic Mutant of Human Gtpase Kras
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Crystal Structure of A Gdp-Bound G12V Oncogenic Mutant of Human Gtpase Kras within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg202
b:13.0
occ:1.00
|
O
|
B:HOH397
|
2.1
|
13.0
|
1.0
|
O
|
B:HOH401
|
2.1
|
14.0
|
1.0
|
O
|
B:HOH318
|
2.1
|
13.7
|
1.0
|
O2B
|
B:GDP201
|
2.1
|
11.1
|
1.0
|
OG
|
B:SER17
|
2.1
|
11.9
|
1.0
|
O
|
B:HOH399
|
2.1
|
13.2
|
1.0
|
HB2
|
B:SER17
|
3.1
|
15.1
|
1.0
|
CB
|
B:SER17
|
3.2
|
12.6
|
1.0
|
PB
|
B:GDP201
|
3.3
|
12.6
|
1.0
|
H
|
B:SER17
|
3.3
|
14.2
|
1.0
|
HA
|
B:PRO34
|
3.4
|
18.0
|
1.0
|
HD2
|
B:TYR32
|
3.4
|
27.6
|
1.0
|
O1B
|
B:GDP201
|
3.5
|
12.9
|
1.0
|
HB3
|
B:SER17
|
3.9
|
15.1
|
1.0
|
N
|
B:SER17
|
3.9
|
11.8
|
1.0
|
HE2
|
B:TYR32
|
3.9
|
29.8
|
1.0
|
HB2
|
B:LYS16
|
4.0
|
13.8
|
1.0
|
OD2
|
B:ASP57
|
4.1
|
14.7
|
1.0
|
CA
|
B:SER17
|
4.1
|
11.7
|
1.0
|
O1A
|
B:GDP201
|
4.1
|
14.9
|
1.0
|
HE2
|
B:LYS16
|
4.1
|
14.2
|
1.0
|
CD2
|
B:TYR32
|
4.2
|
23.0
|
1.0
|
O
|
B:PRO34
|
4.2
|
14.4
|
1.0
|
OD1
|
B:ASP57
|
4.2
|
14.2
|
1.0
|
CA
|
B:PRO34
|
4.3
|
15.0
|
1.0
|
O
|
B:ASP33
|
4.3
|
14.7
|
1.0
|
O3B
|
B:GDP201
|
4.4
|
12.1
|
1.0
|
O3A
|
B:GDP201
|
4.4
|
12.6
|
1.0
|
HA
|
B:SER17
|
4.4
|
14.0
|
1.0
|
O
|
B:ILE36
|
4.4
|
12.9
|
1.0
|
CE2
|
B:TYR32
|
4.5
|
24.8
|
1.0
|
C
|
B:PRO34
|
4.6
|
14.8
|
1.0
|
CG
|
B:ASP57
|
4.6
|
13.4
|
1.0
|
O
|
B:THR58
|
4.6
|
12.6
|
1.0
|
PA
|
B:GDP201
|
4.6
|
14.3
|
1.0
|
HB2
|
B:ALA59
|
4.6
|
18.5
|
1.0
|
HZ2
|
B:LYS16
|
4.7
|
16.2
|
1.0
|
O2A
|
B:GDP201
|
4.8
|
14.3
|
1.0
|
HZ1
|
B:LYS16
|
4.9
|
16.2
|
1.0
|
HA
|
B:ALA59
|
4.9
|
16.2
|
1.0
|
O
|
B:TYR32
|
4.9
|
17.3
|
1.0
|
CB
|
B:LYS16
|
4.9
|
11.5
|
1.0
|
C
|
B:ASP33
|
5.0
|
15.2
|
1.0
|
|
Reference:
J.C.Hunter,
A.Manandhar,
M.A.Carrasco,
D.Gurbani,
S.Gondi,
K.D.Westover.
Biochemical and Structural Analysis of Common Cancer-Associated Kras Mutations. Mol Cancer Res. V. 13 1325 2015.
ISSN: ESSN 1557-3125
PubMed: 26037647
DOI: 10.1158/1541-7786.MCR-15-0203
Page generated: Tue Aug 20 04:11:38 2024
|